4/12
08:00 am
tbph
Theravance Biopharma, Inc. (NASDAQ: TBPH) is now covered by analysts at BTIG Research. They set a "buy" rating and a $21.00 price target on the stock.
Low
Report
Theravance Biopharma, Inc. (NASDAQ: TBPH) is now covered by analysts at BTIG Research. They set a "buy" rating and a $21.00 price target on the stock.
4/12
07:36 am
tbph
Rating for TBPH
Medium
Report
Rating for TBPH